In the BioHarmony Drug Report Database

"Preview" Icon

Scopolamine

Transderm Scop (scopolamine) is a small molecule pharmaceutical. Scopolamine was first approved as Transderm Scop on 1982-01-01. It is used to treat colonic diseases, diverticulitis, dysentery, facial paralysis, and iridocyclitis amongst others in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M1 and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M5.

 

Trade Name

 

Transderm Scop
 

Common Name

 

scopolamine
 

ChEMBL ID

 

CHEMBL569713
 

Indication

 

colonic diseases, diverticulitis, dysentery, facial paralysis, iridocyclitis, postencephalitic parkinson disease, vasomotor rhinitis
 

Drug Class

 

antimuscarinic deliriant antiemetic amnestic

Image (chem structure or protein)

Scopolamine structure rendering